Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

19.89 -0.98 (-4.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
MediWound Deploys NexoBrid® for Emergency Supply
From MediWound Ltd.
Via GlobeNewswire
Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024
These Q4 micro-cap stocks are the ones to buy in on for long-term growth and returns to any investor's portfolio. 
Via InvestorPlace
HC Wainwright & Co. Maintains Buy Rating for MediWound: Here's What You Need To Know
Via Benzinga
MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
Full commercial launch of NexoBrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns 
From MediWound Ltd.
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About MediWound
Via Benzinga
Earnings Outlook For MediWound
Via Benzinga
Recap: MediWound Q1 Earnings
Via Benzinga
Earnings Outlook For MediWound
Via Benzinga
MediWound’s NexoBrid® Highlighted in 20 Oral and Poster Presentations at the 20th European Burns Association Congress
From MediWound Ltd.
Via GlobeNewswire
MediWound to Participate in Fireside Chat at H.C. Wainwright 25th Annual Global Investment Conference
From MediWound Ltd.
Via GlobeNewswire
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study
MediWound joins forces with one of the largest global chronic wound companies in pivotal study for patients with venous leg ulcers 
From MediWound Ltd.
Via GlobeNewswire
5 Analysts Have This to Say About MediWound
Via Benzinga
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
MediWound to join forces with leading chronic wound allograft company in pivotal study for patients with venous leg ulcers 
From MediWound Ltd.
Via GlobeNewswire
MediWound to Report Second Quarter 2023 Financial Results
Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
MediWound Announces Commercial Launch of NexoBrid® in Japan
Kaken Pharmaceutical launches NexoBrid under an exclusive marketing and distribution agreement 
From MediWound Ltd.
Via GlobeNewswire
Preview: MediWound's Earnings
Via Benzinga
3 Micro-Cap Stocks to Buy for Multibagger Returns
These are the micro-cap stocks to buy and they represent companies with decent fundamentals and visibility for robust growth. 
Via InvestorPlace
MediWound Announces Positive Results in Its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
From MediWound Ltd.
Via GlobeNewswire
MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on EscharEx Phase III Study Design
Affirms the clear path forward for the Company’s global Phase III study of EscharEx in venous leg ulcers 
From MediWound Ltd.
Via GlobeNewswire
MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023
From MediWound Ltd.
Via GlobeNewswire
Earnings Scheduled For May 30, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter. 
Via Benzinga
MediWound Reports First Quarter 2023 Financial Results and Provides a Company Update
From MediWound Ltd.
Via GlobeNewswire
MediWound to Report First Quarter 2023 Financial Results
Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
MediWound Announces an Additional $10 Million Award from BARDA
Funding to support emergency stockpiling replenishment, pediatric indication submission, and expanded access treatment protocol extension 
From MediWound Ltd.
Via GlobeNewswire
MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023
From MediWound Ltd.
Via GlobeNewswire
MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update
From MediWound Ltd.
Via GlobeNewswire
MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer
From MediWound Ltd.
Via GlobeNewswire
MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth
From MediWound Ltd.
Via GlobeNewswire
MediWound to Report Fourth Quarter and Year-End 2022 Financial Results
Conference Call and Webcast Scheduled for Thursday, March 16 at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.